REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,271,078 | +280.1% | 41,890 | +238.9% | 0.01% | +250.0% |
| Q1 2023 | $1,123,797 | +38.0% | 12,361 | -42.3% | 0.00% | 0.0% |
| Q4 2022 | $814,283 | +9.2% | 21,426 | +195.9% | 0.00% | 0.0% |
| Q3 2021 | $746,000 | -30.3% | 7,241 | -1.3% | 0.00% | 0.0% |
| Q2 2021 | $1,071,000 | +28.3% | 7,336 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $835,000 | -13.3% | 7,577 | -4.2% | 0.00% | 0.0% |
| Q4 2020 | $963,000 | +110.7% | 7,908 | +67.8% | 0.00% | +100.0% |
| Q3 2020 | $457,000 | -40.4% | 4,714 | -4.1% | 0.00% | -50.0% |
| Q2 2020 | $767,000 | -6.6% | 4,918 | -13.7% | 0.00% | -33.3% |
| Q1 2020 | $821,000 | -15.4% | 5,702 | +20.2% | 0.00% | 0.0% |
| Q4 2019 | $971,000 | +96.6% | 4,742 | -10.1% | 0.00% | +50.0% |
| Q2 2019 | $494,000 | -22.2% | 5,275 | -29.4% | 0.00% | 0.0% |
| Q1 2019 | $635,000 | +30.7% | 7,467 | -13.8% | 0.00% | 0.0% |
| Q4 2018 | $486,000 | – | 8,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $295,368,026 | 59.26% |
| Ally Bridge Group (NY) LLC | 105,558 | $10,762,694 | 13.04% |
| First Light Asset Management, LLC | 1,432,208 | $146,027,928 | 11.44% |
| Boxer Capital, LLC | 1,430,004 | $145,803 | 6.76% |
| MPM BioImpact LLC | 234,478 | $23,907,377 | 4.81% |
| Tri Locum Partners LP | 96,274 | $9,816,097 | 3.65% |
| Altium Capital Management LP | 41,485 | $4,229,811 | 3.20% |
| Ghost Tree Capital, LLC | 85,000 | $8,666,600 | 2.86% |
| KRS Capital Management, LLC | 27,941 | $2,848,864 | 2.85% |
| Sofinnova Investments, Inc. | 322,471 | $32,879,143 | 2.15% |